Investor Outlook: MDA Space revenue jumps 32% in Q1
MDA Space maintained guidance after reporting a first-quarter revenue beat and growing customer demand for its CHORUS program.
ADVERTISEMENT
MDA Space maintained guidance after reporting a first-quarter revenue beat and growing customer demand for its CHORUS program.
Nutrien shares slipped after earnings as investors weighed volatile fertilizer prices and improving long-term crop fundamentals.
Suncor shares fell despite stronger first-quarter earnings, record production and higher refining throughput as oil prices declined.
Thomson Reuters beats Q1 revenue estimates as AI adoption grows, supporting strong performance across key segments.
TMX beat Q1 estimates as trading, listings and data growth boosted results, with the CEO outlining IPO momentum and competition for global listings.
KOHO launches crypto feature, letting users buy and hold digital assets directly within its everyday money app.
Air Canada pulls 2026 guidance amid fuel volatility, as strong demand and revenue growth help offset uncertainty.
Agnico Eagle maintains guidance after a revenue beat, citing strong cash flow, disciplined costs and long-term growth from major mining projects.
Exxon beats Q1 estimates but profit falls amid Iran war, as energy remains a key inflation hedge and investors watch Aritzia and Brookfield earnings.
Canadian Tire expands its Hudson’s Bay Stripes line, using customer data and private brands to drive growth and tap into Canadian consumer demand.
Aecon reports record $10.9B backlog and rising revenue in Q1, with nuclear and utilities growth supporting long-term outlook.
Intel shares jump as AI-driven CPU demand accelerates, boosting earnings but leaving questions about long-term risks.
Netflix shares drop after weak forecast as analysts warn growth may rely too heavily on frequent price increases.
Savaria targets $1.6B revenue by 2030, driven by aging demographics, home accessibility demand and a mix of organic growth and acquisitions.
Morgan Stanley shares rise on strong trading and wealth results as banks post record equity trading revenue.
Johnson & Johnson beats earnings and raises forecast as drug growth and new therapies drive strong quarterly results.